Cameron Cunningham
Amgen Inc.
Cameron R Cunningham is a Senior Scientist at Amgen, Inc. Since joining Amgen in 2016 he has developed and transferred numerous potency assays in support of Amgen products as part of the Process Development Potency and Characterization Assay group. Cameron has also been central to the development and implementation of novel liquid handling technologies utilized in potency assay execution throughout Amgen. Cameron earned his Ph.D. in Microbiology, Immunology, and Molecular Genetics from the University of California, Los Angeles studying the impacts of type I and type II interferons and persistent viral infection on dendritic cell populations.